- £16.97bn
- £16.95bn
- $10.66bn
2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IFRS | IFRS | IFRS | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 93,736 | 36,247 | 26,500 | 6,997 | 10,660 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 91,695 | 33,540 | 23,848 | 7,555 | 8,472 |
Operating Profit | 2,041 | 2,707 | 2,652 | -558 | 2,188 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,922 | 2,908 | 2,676 | -643 | 2,097 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,953 | 2,468 | 2,214 | -997 | 1,712 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 783 | 2,118 | -2,042 | -1,007 | 1,701 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 783 | 2,118 | -2,042 | -1,007 | 1,701 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.815 | 1.01 | 0.903 | -0.311 | 0.626 |
Dividends per Share |